FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
about
Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner.MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.Abnormal expression of is significantly associated with malignant transformation of hepatocytes
P2860
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@ast
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@en
type
label
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@ast
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@en
prefLabel
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@ast
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
FEN1 promotes tumor progressio ...... in non-small-cell lung cancer.
@en
P2093
Chandra S Kathera
Feiyan Pan
Feng Jiang
Haoyan Chen
Hongfang Sun
Jing Zhang
P2860
P304
P356
10.1002/1878-0261.12058
P577
2017-03-29T00:00:00Z